Clinical Trial Update: Kunxian for the Treatment of Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Kunxian in rheumatoid arthritis, with the study status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Kunxian (Tripterygium wilfordii glycosides)

Snippet

Sponsor: Chinese SLE Treatment And Research Group | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN